openPR Logo
Press release

Ursodeoxycholic Acid Market - Witnessing significant traction 2028 | Arcelor Chemicals, Abil Chempharma

11-20-2018 07:55 AM CET | Health & Medicine

Press release from: TMR Research

/ PR Agency: TMR Research
Ursodeoxycholic Acid Market - Witnessing significant traction 2028 | Arcelor Chemicals, Abil Chempharma

Global Ursodeoxycholic Acid Market: Overview

Ursodeoxycholic acid (UDCA) is essentially bile acid ingested in the liquid form or in the form of a tablet to cure gallstones. Those can cure or thwart the progress of cystic fibrosis-related liver disorder. UDCA transforms the bile acid pool by lowering the levels of hydrophobic bile acids. This increases the amount of nontoxic hydrophilic bile acids. Besides, UDCA can slow down the development of gastroesophageal varices and progression to cirrhosis. Further, it can also better chances of survival of patients.

It is said that substantial betterment of liver health can be achieved with UDCA therapy in people afflicted with primary sclerosing cholangitis, intrahepatic cholestasis of pregnancy, nonalcoholic fatty liver disease, total parenteral nutrition-induced cholestasis, cystic fibrosis-associated liver disease, graft related liver disease, and in certain cholestatic liver condition in children.

Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=4221

Global Ursodeoxycholic Acid Market: Drivers and Restraints

Cholestatic liver diseases are at the forefront of driving demand in the global ursodeoxycholic acid market. Rising instances of gall stones and cystic fibrosis is in large part responsible for driving the market. As per 2015 data released by Cystic Fibrosis Foundation, about 30,000 people are afflicted with cystic fibrosis in the U.S. alone.

Women are highly prone to having gallstones when compared to men. This is mainly because of the high levels of estrogen during pregnancy, hormone replacement therapy, and usage of birth control pills. Further, older adults are also highly susceptible to gallstones along with those having a family history of gallstones. While surgery is the most widespread treatment for it, ursodeoxycholic acid can dissolve smaller stones formed mostly of cholesterol. This is having a positive impact on the market.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=4221

Certain side effects of UDCA, on the other hand, are preventing the ursodeoxycholic acid market from achieving its full potential. For instance, treatment with UDCA often leads to diarrhea. As per a study by the National Center for Biotechnology Information (NCBI) published in 2017, the incidence of diarrhea in patients with gallstone being treated with UCDA is almost 2 to 9%. Besides, the treatment also leads to side effects such as vomiting, nausea, dry skin or itching, sleep disturbance, and headache. Cause of such side effects, it cannot be administered in the first trimester of pregnancy.

Global Ursodeoxycholic Acid Market: Trends and Opportunities

The two types of ursodeoxycholic acid available in the market are extraction ursodeoxycholic acid and synthetic ursodeoxycholic acid. Of the two, the synthetic ursodeoxycholic acid is more substantial. Ursodeoxycholic acid finds usage in health products and pharmacy. Between the two, the health products generate most of the demand.

Read Comprehensive Overview of Report @ www.tmrresearch.com/ursodeoxycholic-acid-market

Global Ursodeoxycholic Acid Market: Regional Analysis

With respect to geography, Europe at present rakes in maximum revenue in the global ursodeoxycholic acid market. This is primarily on the back of rising support of the government for liver diseases. Europe is not just the largest supplier of the product but also the largest consumer. North America ursodeoxycholic acid market is another prominent one because of the same reason. Surge in cases of cystic fibrosis is also having a positive impact on the market.

Global Ursodeoxycholic Acid Market: Competitive Landscape

Some of the prominent participants in the global ursodeoxycholic acid market are Arcelor Chemicals, Abil Chempharma, Daewoong Chemical, Biotavia Labs, and Dipharma Francis. Market competition is intense. The overall ursodeoxycholic acid market is highly competitive and with consumer awareness will grow in future.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ursodeoxycholic Acid Market - Witnessing significant traction 2028 | Arcelor Chemicals, Abil Chempharma here

News-ID: 1383944 • Views: 91

More Releases from TMR Research

Farm Animal Drug Market 2025 | Zydus Animal Health Ltd., Zoetis, Inc.
Global Farm Animal Drug Market: Snapshot Farm animal drugs are medicines mainly used for healthcare-based practices for diagnosis, cure, mitigation, treatment, or prevention of diseases that could affect livestock. These medicines need to be used as per strict requirement based on their essentiality to maintain well-being of farm animals. Simply said, farm animal drugs are a key factor supporting the growth of livestock industry all over the globe. Get Sample Copy of
Survey On Innovation: Immune Thrombocytopenia Drugs Market 2028 | Rigel Pharmace …
Immune Thrombocytopenia Drugs Market: Overview The autoimmune disorder of immune thrombocytopenia outcomes in an unusually low level of platelets. Asymptomatic bleeding disorders are immune thrombocytopenia. Only after platelet counts are exceptionally low appear symptoms. These are petechias, skin contusions, bleeding from the rubber gum, among others. While most of the ITP aren’t fatal cases, roughly 3 per cent die from complication like intracranial hemorrhages and infection in chronic refractory ITP patients.
Neglected Tropical Disease Treatment Market Landscape Assessment By Type, Opport …
Global Neglected Tropical Disease Treatment Market: Introduction Relevant issues like sanitation, neatness, and cleanliness still stress a few pieces of the world even today. This outcomes in spike of contaminations and diseases that usually get neglected. They are named as neglected tropical diseases. World Health Organization states that these malady influence almost 1 billion individuals over the globe. This clarifies the upcoming potential for organizations in the global neglected tropical
Business Overview: Uveitis Drugs Market 2028 | Allergan India Private Limited, T …
Global Uveitis Drugs Market: Overview A limited choice of commercial drugs composed of corticosteroid treatments, immunosuppresives and biologics is characteristic of the global uveitis drugs market. Uveitis (Uveitis) is a median eye inflammation (Uvea) known as the uvea tract. The uvea is made up of iris, ciliary and choroids. Certain prevalent causes of uveitis are autoimmune diseases, infection, injury, inflammatory diseases and surgeries. Uveitis-related common symptoms include eye pain, floating

All 26115 Releases


More Releases for Ursodeoxycholic

Global Ursodeoxycholic Acid Industry Market Analysis & Forecast 2018-2023
Global Ursodeoxycholic Acid Industry has been utilized in the administration of puppies with incessant hepatitis and felines with lymphocytic plasmacytic cholangitis. It is accepted to be most useful in scatters where bile poisonous quality assumes an imperative job in the continuous pathology. The adequacy of Global Ursodeoxycholic Acid Industry in veterinary patients has not been certainly settled, in spite of the fact that reports recommend it might have some advantage
Ursodeoxycholic Acid Market 2017-ICE, Grindeks, Mitsubishi Tanabe, Daewoong chem …
Apex Market Reports, recently published a detailed market research study focused on the "Ursodeoxycholic Acid Market" across the global, regional and country level. The report provides 360° analysis of "Ursodeoxycholic Acid Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Ursodeoxycholic Acid industry, and estimates the future trend of Ursodeoxycholic Acid market
Ursodeoxycholic Acid Market 2017 Forecast to 2022
"Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis." Read Detailed Full Report @ https://www.reportsandmarkets.com/reports/global-north-america-europe-and-asia-to-2022-1686998 Scope of the Report: Ursodeoxycholic Acid in Global market, especially in North
Ursodeoxycholic Acid Market- ICE, Grindeks, Mitsubishi, Daewoong chemical, Pharm …
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. And the CAS number
Global Ursodeoxycholic Acid Market 2017 - Zhangshanbelling, Suzhou Tianlu
The motive of this strategic research report entitled "Global Ursodeoxycholic Acid Market 2017" is to provide company officials, industry investors, and industry members with consequential insights to enable them make reliable strategic decisions regarding the opportunities in the global Ursodeoxycholic Acid market. Key Notes On Ursodeoxycholic Acid Market: "Global Ursodeoxycholic Acid Market 2017 "offers crucial insights into the global Ursodeoxycholic Acid market along with the market size and estimates for the duration
Global Ursodeoxycholic Acid Market Insights: Pharmacy, Health Products
"Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3?, 7?-2-hydroxy-5?-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. And the CAS number